Literature DB >> 21684069

Laparoendoscopic single-site surgery in urology: worldwide multi-institutional analysis of 1076 cases.

Jihad H Kaouk1, Riccardo Autorino, Fernando J Kim, Deok Hyun Han, Seung Wook Lee, Sun Yinghao, Jeffrey A Cadeddu, Ithaar H Derweesh, Lee Richstone, Luca Cindolo, Anibal Branco, Francesco Greco, Mohamad Allaf, René Sotelo, Evangelos Liatsikos, Jens-Uwe Stolzenburg, Abhay Rane, Wesley M White, Woong Kyu Han, Georges-Pascal Haber, Michael A White, Wilson R Molina, Byong Chang Jeong, Joo Yong Lee, Wang Linhui, Sara Best, Sean P Stroup, Soroush Rais-Bahrami, Luigi Schips, Paolo Fornara, Phillip Pierorazio, Camilo Giedelman, Jae Won Lee, Robert J Stein, Koon Ho Rha.   

Abstract

BACKGROUND: Laparoendoscopic single-site surgery (LESS) has gained popularity in urology over the last few years.
OBJECTIVE: To report a large multi-institutional worldwide series of LESS in urology. DESIGN, SETTING, AND PARTICIPANTS: Consecutive cases of LESS done between August 2007 and November 2010 at 18 participating institutions were included in this retrospective analysis. INTERVENTION: Each group performed a variety of LESS procedures according to its own protocols, entry criteria, and techniques. MEASUREMENTS: Demographic data, main perioperative outcome parameters, and information related to the surgical technique were gathered and analyzed. Conversions to reduced-port laparoscopy, conventional laparoscopy, or open surgery were evaluated, as were intraoperative and postoperative complications. RESULTS AND LIMITATIONS: Overall, 1076 patients were included in the analysis. The most common procedures were extirpative or ablative operations in the upper urinary tract. The da Vinci robot was used to operate on 143 patients (13%). A single-port technique was most commonly used and the umbilicus represented the most common access site. Overall, operative time was 160±93 min and estimated blood loss was 148±234 ml. Skin incision length at closure was 3.5±1.5 cm. Mean hospital stay was 3.6±2.7 d with a visual analog pain score at discharge of 1.5±1.4. An additional port was used in 23% of cases. The overall conversion rate was 20.8%; 15.8% of patients were converted to reduced-port laparoscopy, 4% to conventional laparoscopy/robotic surgery, and 1% to open surgery. The intraoperative complication rate was 3.3%. Postoperative complications, mostly low grade, were encountered in 9.5% of cases.
CONCLUSIONS: This study provides a global view of the evolution of LESS in the field of minimally invasive urologic surgery. A broad range of procedures have been effectively performed, primarily in the academic setting, within diverse health care systems around the world. Since LESS is performed by experienced laparoscopic surgeons, the risk of complications remains low when stringent patient-selection criteria are applied.
Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21684069     DOI: 10.1016/j.eururo.2011.06.002

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  60 in total

Review 1.  Pure single-port laparoscopic surgery or mix of techniques?

Authors:  Evangelos Liatsikos; Iason Kyriazis; Panagiotis Kallidonis; Minh Do; Anja Dietel; Jens-Uwe Stolzenburg
Journal:  World J Urol       Date:  2011-10-21       Impact factor: 4.226

2.  Surgery: are we likely to see more of LESS in urological surgery?

Authors:  Aditya Bagrodia; Jeffrey A Cadeddu
Journal:  Nat Rev Urol       Date:  2012-03-27       Impact factor: 14.432

Review 3.  Laparoendoscopic single-site surgery in kidney surgery: clinical experience and future perspectives.

Authors:  Panagiotis Kallidonis; Stavros Kontogiannis; Iason Kyriazis; Ioannis Georgiopoulos; Abdulrahman Al-Aown; Jens-Uwe Stolzenburg; Evangelos Liatsikos
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

4.  Laparoendoscopic single-site surgery (LESS) and conventional laparoscopic extravesical repair of vesicouterine fistula: single-center experience.

Authors:  Aly M Abdel-Karim; Mostafa Elmissiry; Ahmed Aboulfotoh; Ahmed Moussa; Salah Elsalmy
Journal:  Int Urol Nephrol       Date:  2013-05-23       Impact factor: 2.370

5.  Robotic-assisted laparoendoscopic single-site radical nephrectomy: first experience with the novel Da Vinci single-site platform.

Authors:  R Mathieu; G Verhoest; S Vincendeau; A Manunta; K Bensalah
Journal:  World J Urol       Date:  2014-02       Impact factor: 4.226

6.  Laparoendoscopic partial nephrectomy in single-incision triangulated umbilical surgery (SITUS) technique: early experience.

Authors:  Mathias Wolters; Florian Imkamp; Lucy Wohlatz; Stephan Jutzi; Christoph A von Klot; Markus A Kuczyk; Axel S Merseburger; Ute Walcher; Udo Nagele; Thomas R W Herrmann
Journal:  World J Urol       Date:  2014-05-24       Impact factor: 4.226

7.  Retroperitoneal laparoendoscopic single-site surgery for the treatment of retrocaval ureter.

Authors:  Ning Kang; Jun-hui Zhang; Yi-nong Niu; Jian-wen Wang; Xi-quan Tian; Yan Yong; Nian-zeng Xing
Journal:  World J Urol       Date:  2012-10-10       Impact factor: 4.226

8.  A randomized, prospective study of laparoendoscopic single-site plus one-port versus mini laparoscopic technique for live donor nephrectomy.

Authors:  Kyu Won Lee; Sae Woong Choi; Yong Hyun Park; Woong Jin Bae; Yong Sun Choi; U-Syn Ha; Sung-Hoo Hong; Ji Youl Lee; Sae Woong Kim; Hyuk Jin Cho
Journal:  World J Urol       Date:  2018-02-02       Impact factor: 4.226

Review 9.  Oncologic outcomes obtained after laparoscopic, robotic and/or single port nephroureterectomy for upper urinary tract tumours.

Authors:  Maria J Ribal; J Huguet; A Alcaraz
Journal:  World J Urol       Date:  2012-10-25       Impact factor: 4.226

10.  Laparoendoscopic single-site versus conventional laparoscopic radical nephrectomy for renal cell cancer in patients with increased comorbidities and previous abdominal surgery: preliminary results of a single-centre retrospective study.

Authors:  Christopher Springer; Antonino Inferrera; Felix Kawan; André Schumann; Paolo Fornara; Francesco Greco
Journal:  World J Urol       Date:  2012-12-16       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.